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M
edical researchers—and 
scientists in general—place 
a high value on their ability 
to make independent judgments. Yet 
the same group often seeks metrics 
to validate their subjective opinions. 
One could argue that as rationalists, 
scientists should have little use for 
subjectivity, opinions should be 
supported by veriﬁ  able data, and the 
subjective view of a paper’s worth 
should not be a consideration in 
editorial decisions about which papers 
to publish. In reality, however, given 
the sheer volume of papers published 
each day, the subjective value of 
a paper’s “worth” is an accepted 
criterion in scientiﬁ  c publication as 
no individual could possibly read all 
papers published in their own ﬁ  eld 
without some guidance as to their likely 
importance. 
So, like other journals presented with 
many objectively sound submissions, 
the editors at PLoS Medicine have 
ultimately to make subjective decisions 
about which papers we accept. As an 
indication of how far we have come in 
establishing a “top-tier” open-access 
medical journal, PLoS Medicine now 
has a rejection rate of greater than 80 
percent. We feel that the unwanted 
side-effect of this rejection rate—and 
the authors of rejected papers would 
agree—is that we are turning away many 
valuable contributions. Some of the 
papers we reject are clearly not suitable 
for a general medical journal, but for 
others that decision is less clear-cut, 
and most of the submitted manuscripts 
contain valuable data, even if they 
sometimes fall short of supporting more 
ambitious conclusions. 
As an organization whose vision 
is a world of scientiﬁ  c publishing 
where there is an open-access journal 
for every paper worth publishing, it 
is essential that PLoS continues to 
create additional open-access venues 
to help reach this goal. Two recent 
developments take us closer.
PLoS Clinical Trials (http:⁄⁄www.
plosclinicaltrials.org) was launched ﬁ  ve 
months ago and has already started 
to broaden the scope of clinical trials 
reporting by publishing the results 
of randomized clinical trials from all 
medical and public health disciplines 
without regard to the direction of the 
results, a trial’s size, or its “importance.”
Broadening the range of open-
access options further, PLoS has 
recently announced the forthcoming 
launch of a new and very different 
publishing project. PLoS ONE 
(http:⁄⁄www.plosone.org) will be 
an open-access venue for research 
from every discipline, including all 
areas of medicine and public health, 
and will use the capabilities of the 
Internet to allow readers to participate 
directly in the publishing process. 
The growing availability of online 
tools that allow users to share, ﬁ  lter, 
link, and annotate online information 
makes it much easier for readers to 
ﬁ  nd the information that is of most 
interest to them, and to add value to 
it. By making use of these advances, 
we hope that PLoS ONE will lead the 
way towards a new form of scientiﬁ  c 
discourse that maintains those 
elements of conventional journals 
that beneﬁ  t the scientiﬁ  c and medical 
community but which also embraces 
the potential of the Internet to create 
a more interactive, community-driven 
literature that invites participation from 
anyone who has a valuable contribution 
to make. 
Papers published by PLoS ONE will be 
held to rigorous standards of scientiﬁ  c 
quality. Experts will assess whether 
the results are valid and presented 
in sufﬁ  cient detail to allow critical 
evaluation by readers, and whether 
the conclusions are fully supported. 
Speculation is encouraged, but must 
be clearly marked as such. However, 
subjective considerations such as 
“likely impact,” “degree of advance,” 
or “interest to a general reader” will 
not play a role in deciding whether an 
article should be published. Hence, 
PLoS ONE will be able to publish a 
much wider range of papers than 
PLoS Medicine, for example, can now 
accommodate. Editorial decisions will 
be reached rapidly by an extensive 
editorial board, and accepted articles 
will be published (in PDF and fully 
tagged XML formats) in as little as two 
weeks after acceptance. 
And, crucially, published papers will 
be exposed to post-publication peer 
review. Readers will have the tools 
to add comments, questions, related 
data, and ratings to each article, and 
authors will be able to update, clarify, 
and further discuss their ﬁ  ndings. PLoS 
ONE will empower researchers and 
consumers of research to engage in an 
open discussion on published articles. 
The goal is to capture the varied and 
extremely valuable assessment of 
papers that occurs after publication 
in a way that is not possible within the 
limits of conventional Correspondence 
or Letters sections. It is our hope that 
such post-publication activity will have 
many beneﬁ  ts: papers that emerge as 
inﬂ  uential for a particular ﬁ  eld will 
attract signiﬁ  cant annotation and 
comment, beneﬁ  ting the authors as 
well as the readers; discussion will help 
to link previously unconnected groups 
or even communities of researchers; 
free access to this content and 
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interaction will help to level out some 
of the inequalities between researchers 
in privileged settings with easy access 
to information and those who are less 
well connected. No doubt, there will be 
some surprises too. 
Like the other PLoS journals, PLoS 
ONE will have publication charges. 
(The PLoS fee waiver policy applies to 
PLoS ONE authors just as for our other 
journals: if you cannot pay any or part 
of the publication fee, we will waive 
or lower it, and editors and reviewers 
who make decisions about publication 
have no knowledge of who can pay.) 
Annotation, on the other hand, carries 
no charge; all contributions that are 
deemed valuable will be posted rapidly 
and are citable. 
PLoS ONE will be our prototype, but 
the open-source software that allows 
this level of online interaction will be 
added to PLoS Medicine shortly after 
the launch of PLoS ONE later this year. 
What this means is that although we will 
maintain “subjective” editorial criteria 
for PLoS Medicine, this assessment itself 
will be open to broader community 
opinion. We are excited that we will be 
able to accommodate a much larger 
number of contributors—authors and 
annotators—to all PLoS publications 
and invite you to participate.  
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